Thiyagaraja Ravindran
Direttore/Membro del Consiglio presso UCB Fipar SA
Profilo
Thiyagaraja Ravindran is currently a Director at UCB Fipar SA since 2018.
Prior to this, he worked as a Director at Zogenix, Inc.
Posizioni attive di Thiyagaraja Ravindran
| Società | Posizione | Inizio |
|---|---|---|
UCB Fipar SA
 UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Direttore/Membro del Consiglio | 09/02/2018 |
Precedenti posizioni note di Thiyagaraja Ravindran
| Società | Posizione | Fine |
|---|---|---|
| ZOGENIX, INC. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
UCB Fipar SA
UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Finance |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Thiyagaraja Ravindran
